1. Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis
- Author
-
Wei Chen, Pu Cheng, Feng Xu, Shimin Wang, Guoming Hu, Liming Huang, and Kefang Zhong
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Lymphovascular invasion ,Colorectal cancer ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,Surgical oncology ,Internal medicine ,Neoplasms ,Eosinophilia ,Genetics ,medicine ,Carcinoma ,Favorable outcome ,Tumor Microenvironment ,Humans ,business.industry ,Hazard ratio ,Odds ratio ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Prognosis ,Tumor-associated tissue eosinophilia ,Meta-analysis ,030104 developmental biology ,Tumor progression ,030220 oncology & carcinogenesis ,Human solid tumor ,medicine.symptom ,business ,Research Article - Abstract
Background Activated eosinophils have been deemed to affect carcinogenesis and tumor progression via various mechanisms in tumor microenvironment. However, the prognostic role of tumor-associated tissue eosinophilia (TATE) in human cancers remains controversial. Therefore, we conducted this meta-analysis to better comprehend the association between TATE and clinical outcomes of patients. Methods We searched PubMed, Embase and EBSCO to determine the researches assessing the association between TATE and overall survival (OS) and/or disease-free survival (DFS) in patients with cancer, then combined relevant data into hazard ratios (HRs) or odds ratio (OR) for OS, DFS and clinicopathological features including lymph node metastasis etc. with STATA 12.0. Results Twenty six researches with 6384 patients were included in this meta-analysis. We found that the presence of TATE was significantly associated with improved OS, but not with DFS in all types of cancers. In stratified analyses based on cancer types, pooled results manifested that the infiltration of eosinophils was remarkably associated with better OS in esophageal carcinoma and colorectal cancer. In addition, TATE significantly inversely correlated with lymph node metastasis, tumor stage and lymphatic invasion of cancer. Conclusion TATE promotes survival in cancer patients, suggesting that it is a valuable prognostic biomarker and clinical application of biological response modifiers or agonists promoting TATE may be the novel therapeutic strategy for patients.
- Published
- 2020